Emily L Young Johnson, CNM in Decorah, IA - Medicare

Emily L Young Johnson, CNM is a medicare enrolled "Advanced Practice Midwife" in Decorah, Iowa. Her current practice location is 901 Montgomery St, Decorah, Iowa. You can reach out to her office (for appointments etc.) via phone at (563) 382-2911.

Emily L Young Johnson is licensed to practice in Iowa (license number B103305) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1427056779.

Contact Information

	Emily L Young Johnson, CNM
	901 Montgomery St, Decorah, IA 52101-2325
	(563) 382-2911
	(563) 387-3102

Provider's Profile

Full Name	Emily L Young Johnson
Gender	Female
Speciality
Experience	Years
Location	901 Montgomery St, Decorah, Iowa
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Emily L Young Johnson attended and graduated from in

NPI Data:

NPI Number: 1427056779
Provider Enumeration Date: 07/11/2005
Last Update Date: 08/06/2013

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Emily L Young Johnson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427056779	NPI	-	NPPES
B103305	Other	IA	LICENSE NUMBER
1444158	Medicaid	IA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
367A00000X	Advanced Practice Midwife	B103305 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Emily L Young Johnson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Emily L Young Johnson, CNM 901 Montgomery St, Decorah, IA 52101-2325 Ph: (563) 382-2911	Emily L Young Johnson, CNM 901 Montgomery St, Decorah, IA 52101-2325 Ph: (563) 382-2911

News Archive

EPA approves BASF's Aseptrol S10 - Tab for H1N1 sanitization operations

BASF today announced that the Environmental Protection Agency (EPA) has approved the use of Aseptrol® S10 - Tab in H1N1 sanitization operations in institutional and industrial facilities, such as, schools, hospitals, government buildings, retail and restaurants, and recreational facilities. Aseptrol S10 - Tab is based on Chlorine dioxide (CIO2) release technology.

New fruit fly model study reveals metabolic pathway that can be targeted to treat FXS patients

Fragile X syndrome (FXS) is the most common genetically inherited cause of intellectual disability in humans. New research shows how the hormone insulin - usually associated with diabetes - is involved in the daily activity patterns and cognitive deficits in the fruitfly model of FXS, according to a new study from the Perelman School of Medicine at the University of Pennsylvania published online this month in Molecular Psychiatry in advance of the print issue.

Nonin Medical introduces new Xpod family for device manufacturers

Nonin Medical, Inc., the inventor of the world's first low-power pulse oximeter for OEM and a leader in noninvasive physiological monitoring, announced the worldwide launch of its low power Xpod, Model 3012LP, OEM Pulse Oximeter for medical monitoring manufacturers.

First biodegradable gene delivery system efficiently penetrates human airway mucus barrier of lung tissue

Researchers at the Johns Hopkins University School of Medicine, Johns Hopkins University Department of Chemical and Biomolecular Engineering, and Federal University of Rio de Janeiro in Brazil have designed a DNA-loaded nanoparticle that can pass through the mucus barrier covering conducting airways of lung tissue — proving the concept, they say, that therapeutic genes may one day be delivered directly to the lungs to the levels sufficient to treat cystic fibrosis (CF), chronic obstructive pulmonary disease, asthma and other life-threatening lung diseases.

Emily L Young Johnson, CNM - Medicare in Decorah, IA